ANATOLIAN JOURNAL OF CARDIOLOGY, vol.17, no.5, pp.353-361, 2017 (Peer-Reviewed Journal)
Article / Article
ANATOLIAN JOURNAL OF CARDIOLOGY
Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
new oral anticoagulants, atrial fibrillation, embolic complication, bleeding, ATRIAL-FIBRILLATION, STROKE INCIDENCE, CASE-FATALITY, RISK-FACTORS, MORTALITY, WARFARIN, THROMBOEMBOLISM, TRENDS
Objective: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). In this study, we aimed to evaluate the current patterns of NOACs treatment in Turkey. Moreover, demographic and clinical parameters and bleeding and/or embolic events under NOACs treatment were analyzed.